3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
5
Rectal Neoplasms
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Glioma
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Astrocytoma
3
Sarcoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Carcinoma, Squamous Cell
2
Breast Neoplasms
2
Brain Neoplasms
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Rhabdomyosarcoma
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Pelvic Neoplasms
1
Pathologic Complete Response
1
Interventions
Temozolomide
7
Vincristine
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Magnetic Resonance Spectroscopy
4
Irinotecan
4
Cyclophosphamide
4
cabozantinib
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
liposomal doxorubicin
2
ivosidenib
2
Topotecan
2
Radiation
2
Nuclear Medicine Department, Hospital
2
LY3023414
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
talazoparib
1
silmitasertib
1
romiplostim
1
regorafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Surgical Procedures, Operative
×
90 days
×
Clear all
No trials found.